LifeMD, Inc. revenue by segment LFMDP

Annual Quarterly

LifeMD, Inc. splits its revenue into 4 lines in its filings. The largest line in Q2 of fiscal 2026, the quarter ended Jun 30, 2026 was Telehealth Subscription Revenue at $29.3 million, 62% of the total.

USD in millions. The percent under a figure is the change from the same quarter a year earlier.

Line	TTM Jun 30, 2026	Q2 FY2026 Jun 30, 2026	Q1 FY2026 Mar 31, 2026	Q4 FY2025 Dec 31, 2025	Q3 FY2025 Sep 30, 2025	Q2 FY2025 Jun 30, 2025	Q1 FY2025 Mar 31, 2025	Q4 FY2024 Dec 31, 2024	Q3 FY2024 Sep 30, 2024
Revenue	192	47	50	7	60	49	51	5	53
Telehealth Subscription Revenue	114 +8.0% share 59.4%	29 +0.9% share 61.9%	30 +0.9% share 60.6%	27 +8.2% share 378.8%	27 +30.4% share 45.4%	29 share 59.2%	30 share 59.2%	25 share 451.8%	21 share 39.3%
Telehealth	78 -4.1% share 40.6%	18 -10.0% share 38.1%	20 -4.8% share 39.4%	20 -16.3% share 283.2%	20 +3.9% share 33.2%	20 share 40.8%	21 share 40.8%	24 share 436.7%	19 share 36.1%
Work Simpli	—	—	—	—	13 -1.7% share 21.4%	14 share 27.9%	—	14 share 261.8%	13 share 24.6%
Medifast Collaboration Revenue	—	—	—	—	—	—	—	0 share 0.0%	—

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
Listed as: LFMD (Nasdaq), LFMDP (Nasdaq)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: New York, NY
SEC filer status: Accelerated filer
SEC CIK: 948320
Former names: CONVERSION LABS, INC. (until Feb 22, 2021); Immudyne, Inc. (until Jun 19, 2018)

Other Services-Offices & Clinics of Doctors of Medicine companies

All 12 Services-Offices & Clinics of Doctors of Medicine companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.